• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

MSPEA leads acquisition of Korres

  • Tim Burroughs
  • 02 January 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Morgan Stanley Private Equity Asia (MSPEA) and Profex, a Chinese skincare company, have agreed to pay €48.3m for a majority interest in Korres, a listed Greek specialist cosmetics manufacturer.

Nissos, an acquisition vehicle set up by MSPEA and Profex, will buy a 6.6% stake from the company's founder, Giorgos Korres, and 45.7% from other shareholders, according to a filing.

MSPEA and Profex will respectively own 56% and 14% of Nissos. Giorgos Korres and members of his family will exchange their remaining 30% interest in the company for an equal share in the acquisition vehicle.

Korres

  • DEAL:

    Take-private

  • VALUE:

    $69m

  • LOCATION:

    Metamorfosi

  • SECTOR:

    Personal products

  • FOUNDED:

    1996

  • TURNOVER:

    €54.6m

  • EBITDA:

    €8.2m (adjusted)

Once these transactions have been completed, Nissos will hold more than 82% of Korres and launch a mandatory takeover offer for the entire company. The offer price will be €5.08 per share, valuing the entire business at approximately $69m. Korres's stock closed at €4.91 on December 27, the day the deal was announced.

MSPEA and Profex are expected to invest €10m to support the future expansion of Korres. Meanwhile, the company has entered into an exclusive licence-and-supply agreement with Profex covering mainland China, Hong Kong and Macau.

MSPEA is currently investing its fourth pan-regional fund, which closed on $1.7bn in 2014.

Recent activity includes the sale of Chinese convenience store chain Hi-24 to several strategic investors and a proposed $172m privatisation of Nasdaq-listed power-steering components supplier China Automotive Systems.

Company
Established in 1996, Korres develops products based on natural ingredients through cooperation with local farmers.

The company now has a portfolio of 400 herbal products that are distributed to 30 countries in Europe, the Middle East, Asia and North America. Sales came to €54.6m in 2016, up 0.1% year-on-year, while adjusted EBITDA was unchanged at €8.2m, and the net loss widened from €1.4m to €2.3m.

People
Korres
– Giorgos Korres (chairman).

This article was originally published in unquote" sister publication AVCJ

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • CEE
  • Consumer
  • Morgan Stanley
  • Greece
  • Take Private

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013